We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC

Delisted

SGMO was delisted on the 4th of May, 2026.

115 hedge funds and large institutions have $642M invested in SANGAMO THERAPEUTICS INC in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 31 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

789% more call options, than puts

Call options by funds: $93.6M | Put options by funds: $10.5M

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

57% more capital invested

Capital invested by funds: $408M → $642M (+$234M)

35% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 31

22% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 18

4% more funds holding

Funds holding: 111115 (+4)

Holders
115
Holders Change
+4
Holders Change %
+3.6%
% of All Funds
3.34%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.15%
New
22
Increased
42
Reduced
31
Closed
18
Calls
$93.6M
Puts
$10.5M
Net Calls
+$83.1M
Net Calls Change
+$5.8M
Name Holding Trade Value Shares
Change
Change in
Stake
ProShare Advisors
76
ProShare Advisors
Maryland
$440K -$245K -21,288 -40%
Public Employees Retirement Association of Colorado
77
Public Employees Retirement Association of Colorado
Colorado
$424K
TAM
78
Tocqueville Asset Management
New York
$417K
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
$347K -$10.1K -875 -3%
MAM
80
MPM Asset Management
Massachusetts
$312K +$259K +22,487 New
Nisa Investment Advisors
81
Nisa Investment Advisors
Missouri
$306K
UCFA
82
United Capital Financial Advisors
Texas
$277K
ST
83
Stifel Trust
Missouri
$268K +$14.4K +1,250 +7%
Connor, Clark & Lunn Investment Management (CC&L)
84
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$263K -$289K -25,100 -59%
TC
85
TFS Capital
Pennsylvania
$260K +$215K +18,714 New
Comerica Bank
86
Comerica Bank
Texas
$253K -$135K -11,756 -39%
Principal Financial Group
87
Principal Financial Group
Iowa
$237K -$114K -9,921 -37%
Janney Montgomery Scott
88
Janney Montgomery Scott
Pennsylvania
$201K
T
89
TradeWorx
New Jersey
$193K +$160K +13,880 New
BA
90
Bridgewater Advisors
New York
$191K +$159K +13,780 New
RFS
91
Rockefeller Financial Services
New York
$190K +$1.41K +122 +0.9%
QBFM
92
QS Batterymarch Financial Management
New York
$185K
WMSA
93
Weiss Multi-Strategy Advisers
New York
$182K +$150K +13,070 New
GBA
94
Garrison Bradford & Associates
New York
$167K
U
95
UBS
Switzerland
$146K -$3.45K -300 -3%
ORI
96
Oak Ridge Investments
Illinois
$143K +$118K +10,275 New
Group One Trading
97
Group One Trading
Illinois
$112K +$92.8K +8,062 New
Canada Life
98
Canada Life
Manitoba, Canada
$71K +$58.7K +5,100 New
US Bancorp
99
US Bancorp
Minnesota
$69K
Canada Pension Plan Investment Board
100
Canada Pension Plan Investment Board
Ontario, Canada
$57K -$23K -2,000 -33%

SGMO Hedge Fund Activity: Q4 2013 in Review

115 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2013, worth a combined $642M — up 57% from $408M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new SGMO positions and 18 closed out — a net gain of 4 holders — while 42 added to existing stakes and 31 trimmed.

The largest buyer was SAC Capital Advisors, opening a new position worth an estimated $12.9M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $10.1M sold.

  • 115 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2013, up from 111 in Q3 2013.
  • Funds reported $642M of SANGAMO THERAPEUTICS INC stock for Q4 2013, up 57% quarter-over-quarter.
  • 22 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2013 and 18 closed out, a net change of +4 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q4 2013 was SAC Capital Advisors, an estimated $12.9M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q4 2013 was Perceptive Advisors, an estimated $10.1M sold.

Based on aggregated 13F filings for Q4 2013.